Your browser doesn't support javascript.
loading
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort.
Geisen, Ulf M; Berner, Dennis K; Tran, Florian; Sümbül, Melike; Vullriede, Lena; Ciripoi, Maria; Reid, Hayley M; Schaffarzyk, Annika; Longardt, Ann C; Franzenburg, Jeanette; Hoff, Paula; Schirmer, Jan H; Zeuner, Rainald; Friedrichs, Anette; Steinbach, Andrea; Knies, Christine; Markewitz, Robert Dh; Morrison, Peter J; Gerdes, Sascha; Schreiber, Stefan; Hoyer, Bimba F.
Afiliación
  • Geisen UM; Medical Department I, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Berner DK; Medical Department I, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Tran F; Department for Internal Medicine I, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Sümbül M; Institute for Clinical Molecular Biology, Christian-Albrechts-Universitat zu Kiel, Kiel, Schleswig-Holstein, Germany.
  • Vullriede L; Department for Dermatology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Ciripoi M; Medical Department I, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Reid HM; Medical Department I, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Schaffarzyk A; Medical Department I, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Longardt AC; Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Franzenburg J; Department for Pediatrics, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Hoff P; Institute for Clinical Molecular Biology, Christian-Albrechts-Universität zu Kiel, Kiel, Schleswig-Holstein, Germany.
  • Schirmer JH; Institute of Clinical Chemistry, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Zeuner R; Endokrinologikum-Gruppe, Berlin, Germany.
  • Friedrichs A; Medical Department I, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Steinbach A; Medical Department I, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Knies C; Department for Internal Medicine I, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Markewitz RD; Medical Department I, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Morrison PJ; medac GmbH, Wedel, Germany.
  • Gerdes S; Institute of Clinical Chemistry, Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lubeck/Kiel, Germany.
  • Schreiber S; Department for Dermatology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
  • Hoyer BF; Department for Dermatology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
Ann Rheum Dis ; 80(10): 1306-1311, 2021 10.
Article en En | MEDLINE | ID: mdl-33762264
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Huésped Inmunocomprometido / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / COVID-19 / Inflamación Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Huésped Inmunocomprometido / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / COVID-19 / Inflamación Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2021 Tipo del documento: Article País de afiliación: Alemania